The Acolad response took advantage of economies of scale as well as technology to deliver a cost and time-efficient solution. This consists of:
- A combined translation memory (TM) plus machine translation (MT) strategy to reduce the volume of new translations
The content is processed with the legacy TM first, for reuse of legacy-approved translations. MT is then applied to the remaining new content to further reduce volume. Finally, qualified medical device linguists post-edit all output to ensure consistent quality.
- Automation deployed with the customer portal as the entry point
Requests flow directly through to our production automated workflow. This would allow the client to feed requests to us through the customer portal which automatically flowed to our TM+MT processing. In addition, our workflow allows for setup of the program teams so that once ready for linguists, files could automatically flow to those individuals assigned to the program. Many of the tasks handled by the project manager were fully automated.
- Acolad ownership of the review/validation process
Rather than using client reviewers which can delay delivery and result in missed deadlines, we moved to our own validation step using our linguistic resources for this review. This also allowed us to take advantage of our automated workflows.
- Economies of scale advantages
Our client provided a detailed forecast of the workload, which enabled us to provide customized pricing.